Vimarsana
Biggest News Aggregation in the World

Page 14 - Outlayer Item News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Outlayer Item. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Outlayer Item Today - Breaking & Trending Today

New device for lead extraction gets FDA clearance, first in-human use - Vimarsana News

New device for lead extraction gets FDA clearance, first in-human use

Xcardia Innovation Ltd., following the February FDA 510(k) clearance of its device for cardiac pacemaker and defibrillator lead extraction, announced the first-in-human use of the new device. According to a company press release, the new device (Xtractor) is designed with advanced controls, incorporating motor-assisted activation, steering capability, pedal activation and an advanced tip

Source: healio.com
FDA clears low-noise electrophysiology recording technology - Vimarsana News

FDA clears low-noise electrophysiology recording technology

The FDA cleared a new electrophysiology recording technology designed to improve signal acquisition and accuracy of electrogram interpretation in the diagnosis and treatment of complex atrial arrythmias, CathVision announced.The ECGenius EP Recording System includes EP recording technology and a proprietary hardware amplifier to acquire high-fidelity, low-noise, cardiac electrograms to help

Source: healio.com
Patients with DME maintain visual acuity despite fewer injections - Vimarsana News

Patients with DME maintain visual acuity despite fewer injections

DENVER — Patients with diabetic macular edema were able to maintain visual acuity improvements long term despite receiving fewer anti-VEGF injections as treatment progressed, according to a study.

Source: healio.com
Strive Health expands partnership with Illinois nephrology group - Vimarsana News

Strive Health expands partnership with Illinois nephrology group

Strive Health is expanding its relationship with Nephrology Associates of Northern Illinois and Indiana to help manage up to 20,000 patients with kidney disease, according to a company press release.

Source: healio.com
Dapagliflozin was well tolerated among patients hospitalized with COVID-19 - Vimarsana News

Dapagliflozin was well tolerated among patients hospitalized with COVID-19

Among patients hospitalized with COVID-19, dapagliflozin was well tolerated and did not increase risk of AKI in patients, according to data published in the Clinical Journal of the American Society of Nephrology.Further, dapagliflozin was well tolerated among patients with an eGFR below 60 mL/minute per 1.73² and among those with an eGFR above 60 mL/minute per 1.73².

Source: healio.com